Metavention, Inc.
A neuromodulation device that disrupts overactive sympathetic nervous system nerves to treat hypertension and metabolic diseases
- Sector
- Medtech
- Headquarters
- EDEN PRAIRIE, MN
- Latest Form D
- $30M, Dec 2017
- Total capital
- $30M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $30M
- 1 Form D · last Dec 2017
- 106 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 25
- 12 pending · first 2013
- Rank in peer group#92 of 1112
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$30M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1112 peers
Line = medianMedtech · Device
- Granted patents#92 · top 8%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Bobak AzamianExecutive Officer, DirectorNamed in SEC Form D filings
- Kevin HykesExecutive Officer, DirectorNamed in SEC Form D filings
- Kirk NielsenDirectorNamed in SEC Form D filings
- Tony VrbaExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 25 granted of 37- GrantedNeuromodulation For Metabolic Conditions Or SyndromesUSPTOUS 10,856,926
- GrantedNeuromodulation For Metabolic Conditions Or SyndromesUSPTOUS 10,617,460
- GrantedModulation Of Nerves Innervating The LiverUSPTOUS 10,543,034
Show all 37 patent records
- Neuromodulation For Metabolic Conditions Or SyndromesDec 8, 2020 · US 10,856,926Granted
- Neuromodulation For Metabolic Conditions Or SyndromesApr 14, 2020 · US 10,617,460Granted
- Modulation Of Nerves Innervating The LiverJan 28, 2020 · US 10,543,034Granted
- Therapeutic Tissue Modulation Devices And MethodsJan 7, 2020 · US 10,524,859Granted
- Systems And Methods For Modulatng Nerves Or Other TissueMar 7, 2019 · Application 15532650Pending
- Neuromodulation Methods To Alter Glucose LevelsSep 11, 2018 · US 10,070,911Granted
- Methods Of Modulating Nerves Of The Hepatic PlexusSep 4, 2018 · US 10,064,674Granted
- Therapeutic Denervation Of Nerves Surrounding A Hepatic VesselJun 19, 2018 · US 9,999,461Granted
- Modulation Of Targeted Nerve FibersMay 12, 2016 · Application 14896063Pending
- Balloon Catheter Neuromodulation SystemsFeb 23, 2016 · US 9,265,575Granted
- Glucose Alteration MethodsOct 6, 2015 · US 9,149,329Granted
- Hepatic Neuromodulation Using Fluids Or Chemical AgentsAug 25, 2015 · US 9,114,123Granted
- Modulation Of Nerves Innervating The LiverAug 25, 2015 · US 9,114,124Granted
- Hepatic Neuromodulation Using Microwave EnergyJul 28, 2015 · US 9,089,542Granted
- Gastroduodenal Artery NeuromodulationJul 28, 2015 · US 9,089,541Granted
- Hepatic Denervation SystemsJun 23, 2015 · US 9,060,784Granted
- Nerve Modulation To Treat DiabetesMay 19, 2015 · US 9,033,969Granted
- Hepatic Neuromodulation To Treat Fatty Liver ConditionsApr 21, 2015 · US 9,011,422Granted
- Treatment Of Non-alcoholic Fatty Liver DiseaseApr 14, 2015 · US 9,005,190Granted
- Neuromodulation Methods Using Balloon CatheterApr 14, 2015 · US 9,005,191Granted
- Hepatic Artery Nerve Modulation MethodsNov 25, 2014 · US 8,894,639Granted
- Energy Delivery Devices For Hepatic NeuromodulationNov 4, 2014 · US 8,876,815Granted
- Hepatic Neuromodulation DevicesJun 24, 2014 · US 8,758,334Granted
- Modulation Of Nerves That Innervate The LiverMay 20, 2014 · US 8,728,069Granted
- Hepatic Neuromodulation MethodsMay 20, 2014 · US 8,728,070Granted
- Devices For Thermally-induced Hepatic NeuromodulationNov 12, 2013 · US 8,579,891Granted
- Methods For Thermally-induced Hepatic NeuromodulationOct 29, 2013 · US 8,568,399Granted
- Systems And Methods For Modulating Nerves Or Other TissueApplication PCTUS2015063807Pending
- Therapeutic Tissue Modulation Devices And MethodsApplication 62458990Pending
- Hepatic Neuromodulation Using UltrasoundApplication 62130469Pending
- Therapeutic Neuromodulation Of The Hepatic SystemApplication PCTUS2012068630Pending
- Systems And Methods For The Modulation Of Targeted Nerve FibersApplication 62087179Pending
- Therapeutic Tissue Modulation Devices And MethodsApplication PCTUS2017036201Pending
- Modulation Of Targeted Nerve FibersApplication PCTUS2014040949Pending
- Laparoscopic Hepatic DenervationApplication 62723901Pending
- Laparoscopic Hepatic DenervationApplication PCTUS2019048190Pending
- Systems And Methods For Cooling Energy Delivery MembersApplication 62346990Pending
Related companies, and why
- DECISIV INTERVENTIONS, LLCSimilar federal contract value in Medtech · null in contracts
- Promaxo, Inc.Similar federal contract value in Medtech · null in contracts
- SYNERGEYES INCSimilar federal contract value in Medtech · null in contracts
- NUMENTUS TECHNOLOGIES INCSimilar federal contract value in Medtech · null in contracts
- ImmersiveTouch, Inc.Similar federal contract value in Medtech · null in contracts
- Endoluxe, Inc.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .